On Thursday, Shares of Synthetic Biologics Inc. (NYSE:SYN), lost -17.02% to $3.12.
Synthetics Biologics, declared that it has priced an underwritten public offering of 13.3 million shares of common stock at a price of $3.00 per share, for predictable gross proceeds of about $40.0 million. The transaction is predictable to close on or before July 21, 2015, subject to customary closing conditions.
Net proceeds to the Company, after deducting the underwriters’ discounts and other estimated offering expenses, are predictable to be about $37.0 million. The Company has granted the underwriters a 30-day option to purchase up to an additional 2.0 million shares of common stock to cover over-allotments, if any.
William Blair & Company, L.L.C. and RBC Capital Markets, L.L.C. are the joint book-running managers for the offering. BTIG, LLC is serving as co-manager for the offering.
Synthetics Biologics, Inc., a clinical-stage biotechnology company, develops pathogen-specific therapies for serious infections and diseases with a focus on protecting the microbiome. It is developing an oral biologic to protect the gut microbiome (gastrointestinal (GI) microflora) from intravenous (IV) antibiotics for the prevention of C. difficile infection; an oral statin treatment to reduce the impact of methane producing organisms on irritable bowel syndrome with constipation (IBS-C); and a monoclonal antibody combination for the treatment of Pertussis.
Shares of UnitedHealth Group Incorporated (NYSE:UNH), declined -0.74% to $124.93, during its last trading session.
UnitedHealth Group Incorporated, stated second quarter results, highlighted by strong, ongoing growth. “We are seeing consistent growth in response to our ongoing focus on improving the ways we serve people and the health care system as a whole – making processes simpler, information more accessible and easier to use and mitigating costs, all to improve affordability and performance for customers and consumers,” said Stephen J. Hemsley, chief executive officer of UnitedHealth Group.
Merged first half 2015 financial results reflected consistency and balanced performance across the Company. First half 2015 revenues of $72 billion grew 12 percent year-over-year and merged earnings from operations of more than $5.5 billion grew 20 percent, as UnitedHealthcare and Optum each produced double digit percentage enhances in revenues and earnings from operations over the six-month period, driven by organic growth.
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company’s UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; and health care coverage, and health and well-being services to individuals aged 50 and older addressing their needs for preventive and acute health care services.
Finally, Noble Corporation plc (NYSE:NE), ended its last trade with 0.36% gain, and closed at $14.04.
Noble Corporation, declared that its report of drilling rig status and contract information has been updated as of July 16, 2015. The report, titled “Fleet Status Report,” can be found on the Company’s Web site www.noblecorp.com, under the “Investor Relations” section of the Web site.
Noble Corporation plc operates as an offshore drilling contractor for the oil and gas industry worldwide. It owns and operates a fleet of mobile offshore drilling units.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
